UNSPSC 51362604: Pregabalin

A drug indicated for neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, adjunctive therapy for adult patients with partial onset seizures, fibromyalgia and neuropathic pain associated with spinal cord injury.

UNSPSC 51362604 Pregabalin is a Commodity code that nominally identifies a specific pharmaceutical active ingredient, yet the recent state and local procurement activity tagged under it shows little direct solicitation for pregabalin itself. Instead, the opportunities reflect broader pharmaceutical procurement patterns—naloxone and drug deactivation systems for community health, direct-to-manufacturer prescription programs, and generic multi-source pharmaceutical supply agreements. State and local issuing bodies using this code span county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving Minnesota and Oregon). The work being solicited includes medical countermeasure procurement for opioid response, exploration of direct-contracting models for prescription fulfillment, and framework agreements for generic pharmaceutical distribution through authorized wholesalers with cGMP and Drug Supply Chain Security Act compliance requirements.

Recent activity appears concentrated in Texas, Florida, and Minnesota through cooperative purchasing vehicles. Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS, due July 26, 2023) for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries, contract awards on fixed-fee basis with initial two-year term and one-year renewal option, and potential FEMA funding. The Texas Health and Human Services Commission issued an RFI (HHS0017013, posted April 3, 2026) to gather vendor capabilities for direct-to-manufacturer prescription programs designed to bypass traditional pharmacy benefit managers and group purchasing organizations. The Minnesota Multistate Cooperative Purchasing Alliance released an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products through authorized wholesalers, with evaluation weighted 75 percent on price competitiveness and awards effective July 1, 2026. The mismatch between the pregabalin commodity code and the actual solicitation scope suggests this code may be misapplied in state and local procurement tagging; vendors evaluating this code should verify whether pregabalin-specific demand exists separately from the broader pharmaceutical procurement patterns shown here.